Dichotomy of AML1-ETO Functions: Growth Arrest Versus Block of Differentiation

Overview

Journal Mol Cell Biol

Specialty Cell Biology

Date 2001 Jul 21

PMID 11463839

Citations 45

Authors

S A Burel

N Harakawa

L Zhou

T Pabst

D G Tenen

D E Zhang

Affiliations

Soon will be listed here.

Abstract

The fusion gene AML1-ETO is the product of t(8;21)(q22;q22), one of the most common chromosomal translocations associated with acute myeloid leukemia. To investigate the impact of AML1-ETO on hematopoiesis, tetracycline-inducible AML1-ETO-expressing cell lines were generated using myeloid cells. AML1-ETO is tightly and strongly induced upon tetracycline withdrawal. The proliferation of AML1-ETO(+) cells was markedly reduced, and most of the cells eventually underwent apoptosis. RNase protection assays revealed that the amount of Bcl-2 mRNA was decreased after AML1-ETO induction. Enforced expression of Bcl-2 was able to significantly delay, but not completely overcome, AML1-ETO-induced apoptosis. Prior to the onset of apoptosis, we also studied the ability of AML1-ETO to modulate differentiation. AML1-ETO expression altered granulocytic differentiation of U937T-A/E cells. More significantly, this change of differentiation was associated with the down-regulation of CCAAT/enhancer binding protein alpha (C/EBPalpha), a key regulator of granulocytic differentiation. These observations suggest a dichotomy in the functions of AML1-ETO: (i) reduction of granulocytic differentiation correlated with decreased expression of C/EBPalpha and (ii) growth arrest leading to apoptosis with decreased expression of CDK4, c-myc, and Bcl-2. We predict that the preleukemic AML1-ETO(+) cells must overcome AML1-ETO-induced growth arrest and apoptosis prior to fulfilling their leukemogenic potential.

Citing Articles

[Establishment of leukemia cell model with inducible AML1-ETO expression and its effect on fatty acid metabolism in leukemia cells].

Xie W, Yang X, Gu R, Tian Z, Xing H, Tang K Zhonghua Xue Ye Xue Za Zhi. 2023; 44(5):366-372.

PMID: 37550185 PMC: 10440621. DOI: 10.3760/cma.j.issn.0253-2727.2023.05.003.

A direct comparison between AML1-ETO and ETO2-GLIS2 leukemia fusion proteins reveals context-dependent binding and regulation of target genes and opposite functions in cell differentiation.

Zhang Y, Wang X, Xu C, Liu N, Zhang L, Zhang Y Front Cell Dev Biol. 2022; 10:992714.

PMID: 36158200 PMC: 9490184. DOI: 10.3389/fcell.2022.992714.

Alternative polyadenylation dysregulation contributes to the differentiation block of acute myeloid leukemia.

Davis A, Johnson D, Zheng D, Wang R, Jayne N, Liu M Blood. 2021; 139(3):424-438.

PMID: 34482400 PMC: 8777198. DOI: 10.1182/blood.2020005693.

MicroRNA let-7b downregulates AML1-ETO oncogene expression in t(8;21) AML by targeting its 3'UTR.

Johnson D, Davis A, Zhou J, Ball E, Zhang D Exp Hematol Oncol. 2021; 10(1):8.

PMID: 33531067 PMC: 7856722. DOI: 10.1186/s40164-021-00204-7.

Expression of RUNX1-ETO Rapidly Alters the Chromatin Landscape and Growth of Early Human Myeloid Precursor Cells.

Nafria M, Keane P, Ng E, Stanley E, Elefanty A, Bonifer C Cell Rep. 2020; 31(8):107691.

PMID: 32460028 PMC: 7262600. DOI: 10.1016/j.celrep.2020.107691.

References

Mazel S, Burtrum D, Petrie H . Regulation of cell division cycle progression by bcl-2 expression: a potential mechanism for inhibition of programmed cell death. J Exp Med. 1996; 183(5):2219-26. PMC: 2192544. DOI: 10.1084/jem.183.5.2219. View

Borner C . Diminished cell proliferation associated with the death-protective activity of Bcl-2. J Biol Chem. 1996; 271(22):12695-8. DOI: 10.1074/jbc.271.22.12695. View

Smith L, Hohaus S, Gonzalez D, Dziennis S, Tenen D . PU.1 (Spi-1) and C/EBP alpha regulate the granulocyte colony-stimulating factor receptor promoter in myeloid cells. Blood. 1996; 88(4):1234-47. View

Oelgeschlager M, Nuchprayoon I, Luscher B, Friedman A . C/EBP, c-Myb, and PU.1 cooperate to regulate the neutrophil elastase promoter. Mol Cell Biol. 1996; 16(9):4717-25. PMC: 231472. DOI: 10.1128/MCB.16.9.4717. View

Hawley R, Hawley T, Fong A, Quinto C, Collins M, Leonard J . Thrombopoietic potential and serial repopulating ability of murine hematopoietic stem cells constitutively expressing interleukin 11. Proc Natl Acad Sci U S A. 1996; 93(19):10297-302. PMC: 38378. DOI: 10.1073/pnas.93.19.10297. View

Kinsella T, Nolan G . Episomal vectors rapidly and stably produce high-titer recombinant retrovirus. Hum Gene Ther. 1996; 7(12):1405-13. DOI: 10.1089/hum.1996.7.12-1405. View

Klampfer L, Zhang J, Zelenetz A, Uchida H, Nimer S . The AML1/ETO fusion protein activates transcription of BCL-2. Proc Natl Acad Sci U S A. 1996; 93(24):14059-64. PMC: 19494. DOI: 10.1073/pnas.93.24.14059. View

OReilly L, Huang D, Strasser A . The cell death inhibitor Bcl-2 and its homologues influence control of cell cycle entry. EMBO J. 1996; 15(24):6979-90. PMC: 452524. View

Zhang D, Zhang P, Wang N, Hetherington C, Darlington G, Tenen D . Absence of granulocyte colony-stimulating factor signaling and neutrophil development in CCAAT enhancer binding protein alpha-deficient mice. Proc Natl Acad Sci U S A. 1997; 94(2):569-74. PMC: 19554. DOI: 10.1073/pnas.94.2.569. View

10.

Yergeau D, Hetherington C, Wang Q, Zhang P, Sharpe A, Binder M . Embryonic lethality and impairment of haematopoiesis in mice heterozygous for an AML1-ETO fusion gene. Nat Genet. 1997; 15(3):303-6. DOI: 10.1038/ng0397-303. View

11.

Yamanaka R, Kim G, Radomska H, Smith L, Antonson P, Tenen D . CCAAT/enhancer binding protein epsilon is preferentially up-regulated during granulocytic differentiation and its functional versatility is determined by alternative use of promoters and differential splicing. Proc Natl Acad Sci U S A. 1997; 94(12):6462-7. PMC: 21072. DOI: 10.1073/pnas.94.12.6462. View

12.

Thottassery J, Zambetti G, Arimori K, Schuetz E, Schuetz J . p53-dependent regulation of MDR1 gene expression causes selective resistance to chemotherapeutic agents. Proc Natl Acad Sci U S A. 1997; 94(20):11037-42. PMC: 23579. DOI: 10.1073/pnas.94.20.11037. View

13.

Yamanaka R, Barlow C, Castilla L, Liu P, Eckhaus M, Decker T . Impaired granulopoiesis, myelodysplasia, and early lethality in CCAAT/enhancer binding protein epsilon-deficient mice. Proc Natl Acad Sci U S A. 1997; 94(24):13187-92. PMC: 24284. DOI: 10.1073/pnas.94.24.13187. View

14.

Wang J, Hoshino T, Redner R, Kajigaya S, Liu J . ETO, fusion partner in t(8;21) acute myeloid leukemia, represses transcription by interaction with the human N-CoR/mSin3/HDAC1 complex. Proc Natl Acad Sci U S A. 1998; 95(18):10860-5. PMC: 27986. DOI: 10.1073/pnas.95.18.10860. View

15.

Xanthopoulos K . Biological role of the CCAAT/enhancer-binding protein family of transcription factors. J Biol Chem. 1998; 273(44):28545-8. DOI: 10.1074/jbc.273.44.28545. View

16.

Lutterbach B, Westendorf J, Linggi B, Patten A, Moniwa M, Davie J . ETO, a target of t(8;21) in acute leukemia, interacts with the N-CoR and mSin3 corepressors. Mol Cell Biol. 1998; 18(12):7176-84. PMC: 109299. DOI: 10.1128/MCB.18.12.7176. View

17.

Gelmetti V, Zhang J, Fanelli M, Minucci S, Pelicci P, Lazar M . Aberrant recruitment of the nuclear receptor corepressor-histone deacetylase complex by the acute myeloid leukemia fusion partner ETO. Mol Cell Biol. 1998; 18(12):7185-91. PMC: 109300. DOI: 10.1128/MCB.18.12.7185. View

18.

Banker D, Radich J, Becker A, Kerkof K, Norwood T, Willman C . The t(8;21) translocation is not consistently associated with high Bcl-2 expression in de novo acute myeloid leukemias of adults. Clin Cancer Res. 1998; 4(12):3051-62. View

19.

Reed J . Bcl-2 family proteins. Oncogene. 1999; 17(25):3225-36. DOI: 10.1038/sj.onc.1202591. View

20.

Lutterbach B, Hiebert S . Role of the transcription factor AML-1 in acute leukemia and hematopoietic differentiation. Gene. 2000; 245(2):223-35. DOI: 10.1016/s0378-1119(00)00014-7. View